Survey shows pharmacists are confident substituting interchangeable biosimilars for brand biologics
A survey by Xcenda, published in the Academy of Managed Care Pharmacy’s March edition of “Journal of Managed Care and Specialty Pharmacy,” showed that 75 percent of pharmacists are most confident substituting interchangeable biosimilars for brand biologics when products share non-property name. Read More »